Rania El Botty
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
ESR1-Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer.
Journal: Cancer research
Published: April 13, 2025
Targeting WEE1 kinase as a therapeutic strategy in ATIP3-deficient breast cancers.
Journal: Cancer letters
Published: January 06, 2025
Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study.
Journal: Cancer research communications
Published: August 21, 2024
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.
Journal: Nature
Published: April 03, 2024
Uracil processing by SMUG1 in the absence of UNG triggers homologous recombination and selectively kills BRCA1/2-deficient tumors.
Journal: Molecular cell
Published: March 22, 2024
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer.
Journal: Science translational medicine
Published: February 28, 2024
In vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts.
Journal: Frontiers in oncology
Published: June 03, 2022
Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.
Journal: Nature genetics
Published: February 20, 2021
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.
Journal: Breast cancer research : BCR
Published: October 05, 2020
In vitro bone metastasis dwelling in a 3D bioengineered niche.
Journal: Biomaterials
Published: August 04, 2020
Last Updated: 09/26/2026